The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin-Reference-Cited by-同舟云学术

The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin

Published:2010-08-13 Issue:2 Volume:26 Page:498-508
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Stylianou Kostas,Petrakis Ioannis,Mavroeidi Vasiliki,Stratakis Stavros,Vardaki Eleftheria,Perakis Kostas,Stratigis Spyros,Passam Andreas,Papadogiorgaki Eva,Giannakakis Kostas,Nakopoulou Lydia,Daphnis Eugene

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/26/2/498/17107976/gfq496.pdf

Reference48 articles.

1. Targeting phosphoinositide 3-kinase: moving towards therapy;Marone;Biochim Biophys Acta,2008

2. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus;Wu;J Clin Invest,2007

3. Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion;Barber;J Immunol,2006

4. Gain-of-function polymorphism in mouse and human Ltk: implications for the pathogenesis of systemic lupus erythematosus;Li;Hum Mol Genet,2004

5. New immuno suppresor strategies in the treatment of murine lupus nephritis;Alperovich;Lupus,2007

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal models of systemic lupus erythematosus (SLE);Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Dihydroartemisinin ameliorates experimental autoimmune myasthenia gravis by regulating CD4+ T cells and modulating gut microbiota;International Immunopharmacology;2024-09

3. Therapeutic potential of Nelumbo nucifera Linn. in systemic lupus erythematosus: Network pharmacology and molecular modeling insights;Lupus;2024-08-13

4. Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus;International Immunopharmacology;2024-06

5. Potential therapies targeting metabolic pathways in systemic lupus erythematosus;Clinical Immunology;2024-06